# Biomarin Pharmaceutical Inc: Form 8-K, filed Mar 3, 2025

- Company: [Biomarin Pharmaceutical Inc](/companies/bmrn.md) (CIK 1048477)
- Form: 8-K
- Filed: 2025-03-03
- Accepted by EDGAR: Mar 3, 2025, 16:05 ET
- Period: 2025-02-25
- Accession: 0001193125-25-044103
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1048477/000119312525044103/d38831d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1048477/000119312525044103/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1048477/000119312525044103/d38831d8k.htm

Filed Mar 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-044103. Last ingested by Listed: Nov 4, 2026, 16:43 ET. No prices; not investment advice.